Cytochrome P450 metabolites of arachidonic acid in the control of renal function

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 1, 2001, Pages 81-87

  Maier, Kristopher G ^a   Roman, Richard J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ARACHIDONIC ACID DERIVATIVE; CALCIUM CHANNEL; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSATRIENOIC ACID; POTASSIUM CHANNEL;

ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; CHLORIDE TRANSPORT; DIABETES MELLITUS; HEPATORENAL SYNDROME; HUMAN; HYPERTENSION; KIDNEY; KIDNEY FUNCTION; KIDNEY METABOLISM; NONHUMAN; POTASSIUM TRANSPORT; PREGNANCY TOXEMIA; PRIORITY JOURNAL; RAT; REVIEW; SODIUM TRANSPORT;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; KIDNEY TUBULES; PROTEIN ISOFORMS; RENAL CIRCULATION;

EID: 0035138432     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200101000-00013     Document Type: Review

References (86)

1. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone
2. P450 eicosanoids: A novel signaling pathway regulating renal function
3. 20-HETE and the kidney: Resolution of old problems and new beginnings
4. Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback
5. Localization of cytochrome P-450 4A isoforms along the rat nephron
6. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading
7. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney
8. Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney
9. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles
10. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries
11. Afferent arteriolar vasodilation to the sulfonimide analog of 11,12-epoxyeicosatrienoic acid involves protein kinase A
12. +-channel activity
13. Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: Role of a cytochrome P450 metabolite
14. Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart
15. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo
16. Endogenous nitric oxide and epoxyeicosatrienoic acids modulate angiotensin II-induced constriction in the rabbit afferent arteriole
17. 2 and modulation by lipoxygenase and P-450 pathways
18. The epoxygenase pathway contributes to the nitric oxide-independent afferent arteriolar vasodilation to bradykinin
19. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney
20. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone
21. Cytochrome P450 2C is an EDHF synthase in coronary arteries
22. + channels in coronary smooth muscle through a guanine nucleotide binding protein
23. Ca channels
24. + channels in pituitary GH (32) cells
25. + channel in renal arterioles
26. Inhibitors of cytochrome P-450 attenuate the myogenic response to dog renal arcuate arteries
27. Inhibitors of P450 alter afferent arteriolar reponses to elevations in pressure
28. Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness
29. Inhibition of renal vascular production of 20-hydroxyeicosatetraenoic acid impairs autoregulation of renal blood flow
30. Cytochrome P450 omega/omega 1 hydroxylase-derived eicosanoids contribute to endothelin(A) and endothelin(B) receptor-mediated vasoconstriction to endothelin-1 in the rat preglomerular arteriole
31. Cytochrome P450 and cyclooxygenase metabolites contribute to the endothelin-1 afferent arteriolar vasoconstrictor and calcium responses
32. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction
33. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide
34. + channel activity and vascular tone in renal arterioles
35. Renal cytochrome P450 ω-hydroxylase and epoxygenase are differentially modified by nitric oxide and sodium chloride
36. Functional response of the rat kidney to inhibition of nitric oxide synthesis: Role of cytochrome P450-derived arachidonate metabolites
37. Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles
38. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C
39. 20-HETE mediates calcium/calmodulin dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
40. Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling
41. +-ATPase
42. The renal dopamine system
43. 20-Hydroxyeicosatetraenoic acid (20-HETE) activates protein kinase C
44. +-ATPase activity in the proximal tubule: Role of protein kinase C pathway and of eicosanoids
45. 20-HETE mediates the effect of parathyroid hormone and protein kinase C on renal phosphate transport
46. Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites
47. Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport
48. Cytochrome P-450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb
49. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells
50. + channel in the thick ascending limb of the rat kidney
51. + channels in the TAL
52. Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats
53. - cotransport via 20-HETE and PKC in medullary thick ascending limb
54. - absorption via a cytochrome P-450-dependent pathway in MTAL
55. P-450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb
56. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: Characterization of selective inhibitors
57. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR
58. 20-HETE agonists and antagonists in the renal circulation
59. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys
60. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: Arachidonic acid ω-hydroxylation and 11,12-epoxidation by CYP4A2 protein
61. Kinetic profile of the rat CYP4A isoforms: Arachidonic acid metabolism and isoform-specific inhibitors
62. Deduced amino acid sequence of a murine cytochrome P-450 Cyp4A protein: Developmental and hormonal regulation in liver and kidney
63. A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans
64. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11
65. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11
66. Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase
67. Isolation of preferential expressed genes in the kidneys of hypertensive rats
68. Renal cytochrome P450-dependent arachidonic acid metabolism: Intrarenal localization and hormonal regulation in spontaneously hypertensive rats
69. Renal cytochrome P4504A activity and salt-sensitivity in spontaneously hypertensive rats
70. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats
71. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats
72. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats
73. Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension
74. Contribution of Ras GTPase/MAP kinase and deoxycorticosterone-salt-induced hypertension
75. 20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive rats
76. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats
77. Cytochrome P4504A genotype cosegregates with hypertension in Dahl S rats
78. Fenofibrate lowers blood pressure in two genetic models of hypertension
79. Effects of lipid-lowering agents in the Dahl salt-sensitive rat
80. Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats
81. Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats
82. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induced hypertension in rats fed a high salt diet
83. Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE
84. Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporin-induced nephrotoxicity
85. Changes in cytochrome P450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: Relationship to dietary fats and pathologic liver injury
86. Endogenous biosynthesis of arachidonic acid epoxides in humans: Increased formation in pregnancy-induced hypertension